Medication info

Linagliptin 5 mg Tablets

Prescription medicationTablet
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
Bright red, round film-coated tablets with a convex shape on both sides and sharp edges.
Packaging
30 tablets (10 tablets/PTP) x 3
Approval status
Active

MFDS item code 201902174 · Approved 2019.04.10

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this drug is 5mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to help improve blood sugar control in patients with type 2 diabetes. It is used as an adjunct to dietary and exercise therapy and can be administered alone. If the patient has not used diabetes medications previously or if it is difficult to control blood sugar with monotherapy, it can be combined with metformin. Additionally, if blood sugar control is insufficient with monotherapy of metformin or sulfonylureas, this medication is used together. It is also combined when control is difficult with insulin therapy, and can enhance therapeutic effects even when treatment is insufficient with multiple medications. This medication improves blood sugar control in patients with type 2 diabetes.

Dosage and Administration

Adult dosage

The recommended dose of this drug is 5mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.

Precautions

This medication should not be used in patients with allergies to the active ingredient or other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is required when used with other medications that may cause hypoglycemia, especially insulin or sulfonylurea class medications. In this case, the risk of hypoglycemia may increase, and dosage adjustments may be necessary. Experience with administration in patients with heart failure is limited, so it should be used cautiously. Acute pancreatitis may occur, so if persistent and severe abdominal pain appears, stop taking the medicine immediately and consult a doctor. A skin condition called bullous pemphigoid may occur, so if blisters or skin irritation appear, it should be reported to a doctor immediately. During the use of this medication, joint pain may worsen or disabilities may arise, hence consulting a doctor is necessary if these symptoms occur. Although the potential for interactions with other medications is low, caution may be required when taken with certain medications. Pregnant or breastfeeding women should consult a physician before using this medication. Safety and efficacy have not been established in children under 10 years of age, and therefore it is not recommended. Elderly patients can use it without special dosage adjustments, but patients with impaired kidney or liver function may also be given it without separate dosage adjustments. In case of overdose, immediate medical attention should be sought, and general supportive measures may be required. This medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

  • Hypoglycemia
  • angioedema
  • urticaria
  • cough
  • pancreatitis
  • constipation
  • oral ulcer formation
  • rash
  • vesicular dermatitis
  • severe and disabling arthralgia
Show 143 more
  • rhabdomyolysis
  • weight gain
  • increased lipase
  • increased amylase
  • dyspepsia
  • edema
  • facial swelling
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • abdominal pain
  • ileocolitis
  • intestinal obstruction
  • gastritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer’s dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • anemia
  • nausea
  • diarrhea
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • viral upper respiratory infection
  • upper respiratory infection
  • herpes zoster
  • tinea capitis
  • rhinitis
  • soft tissue infection
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • hypercholesterolemia
  • inadequate control of diabetes
  • malnutrition
  • hyponatremia
  • headache
  • paresthesia
  • postherpetic neuralgia
  • hemiparesis
  • syncope
  • drowsiness
  • chest discomfort
  • asthenia
  • pain
  • nosebleed
  • oropharyngeal pain
  • dysphonia
  • allergic rhinitis
  • exertional dyspnea
  • wet cough
  • rhinorrhea
  • pulmonary mass
  • osteoarthritis
  • limb pain
  • increased triglycerides in blood
  • increased urine albumin/creatinine ratio
  • positive urine leukocytes
  • decreased hemoglobin
  • increased potassium in blood
  • increased creatinine in blood
  • increased creatine phosphokinase enzyme
  • increased ALT
  • increased AST
  • male-pattern hair loss
  • hyperhidrosis
  • hair loss
  • dermatitis
  • anxiety
  • affective disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • bone fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eye
  • glaucoma
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hypotension
  • flushing
  • hepatic steatosis
  • cholelithiasis
  • hearing loss
  • erectile dysfunction
  • goiter
  • pruritus
  • hypertension
  • benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture ingress, at a safe temperature between 1 to 30 degrees Celsius. Storing it this way preserves the efficacy of the medication and prevents deterioration.

Appearance and packaging

Appearance

Bright red, round film-coated tablets with a convex shape on both sides and sharp edges.

Package unit

30 tablets (10 tablets/PTP) x 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.